Acrivon Therapeutics, Inc. Common Stock (NASDAQ: ACRV) last traded at $1.75, down 7.89% on the session. The quote above updates while this page is open; the figures below are drawn from Acrivon Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Acrivon Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ACRV. Its market capitalisation is $74.99 million.
Valuation measures for Acrivon Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $74.99M |
|---|---|
| Enterprise value | $46.00M |
| Price / book | 0.87 |
| Beta | 2.01 |
Trailing-twelve-month figures tagged in Acrivon Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$74.22M |
| EPS (TTM) | -$1.88 |
|---|
| Return on equity | -85.65% |
|---|
| Cash | $41.42M |
|---|
Range and volume for ACRV over the past 52 weeks.
| 52-week high | $3.56 |
|---|---|
| 52-week low | $1.27 |
| Volume | 473.8K |
| Average volume | 340.7K |
| Previous close | $1.90 |
Invest a chosen dollar amount in Acrivon Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ACRV.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.